|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004611,
umls-concept:C0036186,
umls-concept:C0238767,
umls-concept:C0242456,
umls-concept:C0332325,
umls-concept:C0580822,
umls-concept:C0581603,
umls-concept:C0681698,
umls-concept:C1414461,
umls-concept:C1512335,
umls-concept:C1547300,
umls-concept:C1548760,
umls-concept:C1550594
|
|
pubmed:issue |
920
|
|
pubmed:dateCreated |
2002-8-1
|
|
pubmed:abstractText |
The success of infragenicular revascularisation for lower limb ischaemia is limited by the high proportion of patients without ipsilateral long saphenous vein (LSV) of adequate length or quality. The aim of this study was to report the results of an autogenous vein only policy for infragenicular revascularisation utilising contralateral LSV when ipsilateral LSV is inadequate. The treatment and outcome of infection of autogenous grafts with methicillin resistant Staphylococcus aureus (MRSA) is also reported.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-10092890,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-10426969,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-11432131,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-1555080,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-1728673,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-1825048,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-2299743,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-2714455,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-3048531,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-3352069,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-3367435,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-3418827,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-3877178,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-6608800,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-7082972,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-7655976,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-7853601,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-7877222,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-8086114,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-8326658,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-8359299,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-8405497,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-8421340,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-8454085,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-8513909,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-8997026,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-9052436,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-9088770,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-9251636,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-9345238,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-9551060,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12151687-9684651
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0032-5473
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
339-43
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12151687-Adult,
pubmed-meshheading:12151687-Aged,
pubmed-meshheading:12151687-Aged, 80 and over,
pubmed-meshheading:12151687-Anti-Bacterial Agents,
pubmed-meshheading:12151687-Female,
pubmed-meshheading:12151687-Humans,
pubmed-meshheading:12151687-Infusions, Intravenous,
pubmed-meshheading:12151687-Ischemia,
pubmed-meshheading:12151687-Leg,
pubmed-meshheading:12151687-Male,
pubmed-meshheading:12151687-Methicillin Resistance,
pubmed-meshheading:12151687-Middle Aged,
pubmed-meshheading:12151687-Saphenous Vein,
pubmed-meshheading:12151687-Staphylococcal Infections,
pubmed-meshheading:12151687-Staphylococcus aureus,
pubmed-meshheading:12151687-Surgical Wound Infection,
pubmed-meshheading:12151687-Survival Rate,
pubmed-meshheading:12151687-Tissue and Organ Harvesting,
pubmed-meshheading:12151687-Transplantation, Autologous,
pubmed-meshheading:12151687-Vancomycin
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
An aggressive policy of bilateral saphenous vein harvest for infragenicular revascularisation in the era of multidrug resistant bacteria.
|
|
pubmed:affiliation |
Department of Vascular Surgery, Leicester General Hospital NHS Trust, Gwendolen Road, Leicester LE5 4PW, UK.
|
|
pubmed:publicationType |
Journal Article
|
